Allogene Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Allogene Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $503k | 157k | 3.21 |
| 2023-09-30 | $497k | 157k | 3.17 |
| 2023-06-30 | $2.6M | 533k | 4.94 |
| 2023-03-31 | $2.6M | 533k | 4.94 |
| 2022-09-30 | $5.5M | 506k | 10.80 |
| 2022-06-30 | $4.9M | 426k | 11.40 |
| 2022-03-31 | $3.7M | 403k | 9.11 |
| 2021-12-31 | $5.8M | 390k | 14.92 |
| 2021-09-30 | $10M | 388k | 25.70 |
| 2021-06-30 | $10M | 398k | 26.08 |
| 2021-03-31 | $7.9M | 226k | 34.82 |
| 2020-12-31 | $9.8M | 260k | 37.71 |
| 2020-09-30 | $9.8M | 260k | 37.71 |
| 2020-06-30 | $11M | 246k | 42.82 |
| 2020-03-31 | $3.6M | 183k | 19.44 |
| 2019-12-31 | $5.3M | 204k | 25.98 |
| 2019-09-30 | $5.3M | 195k | 27.26 |
| 2019-06-30 | $5.4M | 200k | 26.85 |
| 2019-03-31 | $5.7M | 198k | 28.91 |
| 2018-12-31 | $2.6M | 96k | 26.93 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas